FDA To Up Topamax Warning Over Birth Defect Data
The U.S. Food and Drug Administration announced Friday that it would amp up the warning label for Ortho-McNeil-Janssen Pharmaceuticals Inc. epilepsy and migraine drug Topamax after new data suggested that using...To view the full article, register now.
Already a subscriber? Click here to view full article